Your browser doesn't support javascript.
loading
Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.
Kim, Wanlim; Han, Ilkyu; Lee, Jong S; Cho, Hwan S; Park, Jong W; Kim, Han-Soo.
Afiliação
  • Kim W; Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea.
  • Han I; Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Korea.
  • Lee JS; Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea.
  • Cho HS; Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
  • Park JW; Orthopaedic Oncology Clinic, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea.
  • Kim HS; Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Korea.
J Surg Oncol ; 117(6): 1223-1231, 2018 May.
Article em En | MEDLINE | ID: mdl-29409122
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Prognostic factors predictive of postmetastasis survival (PMS) in metastatic osteosarcoma are poorly understood. Our aims were to evaluate PMS in patients with high-grade osteosarcoma in extremities, and to identify prognostic factors related to PMS.

METHODS:

A retrospective review of data for 126 patients with metastatic osteosarcoma was conducted. The study population consisted of 70 men and 56 women, with a mean age of 21 years (range 4-75 years). The mean postmetastasis follow-up period was 37 months (range 1-245 months).

RESULTS:

The 5-year PMS rate was 31% and median PMS duration was 22 months. In the multivariate analyses, no metastasectomy (P < 0.001), local recurrence prior to metastasis (P = 0.016), extrapulmonary metastasis (P = 0.006), and poor histologic response to preoperative chemotherapy (P = 0.047) were significant poor prognostic factors. The 5-year PMS without any negative prognostic factor was 60.2%; with one factor, 31.6%; and with more than two factors, 3.6%.

CONCLUSIONS:

PMS in osteosarcoma patients was influenced by primary tumor-related factors such as histologic response to chemotherapy, as well as metastasis-related factors such as complete metastasectomy and metastasis site. A certain group of patients without such poor prognostic factors could be cured even after the development of metastasis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma / Extremidades / Metastasectomia / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma / Extremidades / Metastasectomia / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2018 Tipo de documento: Article